FDA Adverse Event Malfunction Summary report: N

CENTRIFUGAL PUMP SYSTEM WITH TUBING CLAMP

MDR report key: 7205056 · Received January 19, 2018

Report

Report Number
9611109-2018-00062
Event Type
Malfunction
Date Received
January 19, 2018
Date of Event
December 20, 2017
Report Date
June 4, 2018
Manufacturer
LIVANOVA DEUTSCHLAND
Product Code
DWA
PMA / PMN Number
K032213
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

INITIALLY IT WAS REPORTED THAT THE ISSUE IS RELATED TO A S5 SYSTEM WHICH WAS INCORRECT. THE CORRECT DEVICE IS A CENTRIFUGAL PUMP SYSTEM WITH TUBING CLAMP. CONTROL, PUMP SPEED, CARDIOPULMONARY BYPASS. 60-02-50, 60S08704. PMA/510K: K032213. DEVICE MANUFACTURE DATE: 24.01.2011.

Additional Manufacturer Narrative · 0

THE CUSTOMER REQUESTED THAT A REPLACEMENT SCP CONTROL PANEL BE PROVIDED TO BE INSTALLED BY THE USER. THE PANEL WAS PROVIDED AND SUCCESSFULLY INSTALLED. SUBSEQUENT FUNCTIONAL VERIFICATION TESTING FOUND NO FURTHER ISSUES. THE REPLACED DEVICE WAS RETURNED TO LIVANOVA USA FOR FURTHER INVESTIGATION. THE REPORTED ISSUE COULD NOT REPRODUCED DURING VISUAL INSPECTION AND FUNCTIONAL TESTING. AS THE ISSUE COULD NOT BE REPRODUCED, A ROOT CAUSE COULD NOT BE DETERMINED AND NO CORRECTIVE ACTIONS WERE IDENTIFIED. A REVIEW OF THE DHR DID NOT IDENTIFY ANY DEVIATIONS OR NON-CONFORMITIES RELEVANT TO THE ISSUE.

Additional Manufacturer Narrative · 1

LIVANOVA (B)(4) MANUFACTURES THE S5 SYSTEM. THE INCIDENT OCCURRED IN (B)(6). IF ANY ADDITIONAL INFORMATION PERTINENT TO THE REPORTED EVENT IS RECEIVED, IT WILL BE PROVIDED IN A SUPPLEMENTAL REPORT. DEVICE NOT RETURNED.

Description of Event or Problem · 1

LIVANOVA (B)(4) RECEIVED A REPORT THAT A S5 SYSTEM DISPLAYED AN ERROR MESSAGE DURING PROCEDURE. THERE WAS NO REPORT OF PATIENT INJURY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
48564 CENTRIFUGAL PUMP SYSTEM WITH TUBING CLAMP CONTROL, PUMP SPEED, CARDIOPULMONARY BYPASS DWA LIVANOVA DEUTSCHLAND 60-02-50

Patients

Seq Age Sex Outcome Treatment
1